Epidemiology / Biostatistics Intern

'We were blindsided': Blue Cross Blue Shield of Michigan responds to AG complaint. A spokesperson for the company says they 'fundamentally disagree' with the AG's claim of an 'uncompetitive insurance market' in the state. A landmark antitrust lawsuit filed this week by Michigan Attorney General Dana Nessel against Blue Cross Blue Shield of Michigan has "blindsided" the health insurance provider, a spokesperson for the company told Local 4. The lawsuit, filed in the U.S. District Court Eastern District of Michigan on behalf of the state of Michigan and its residents, accuses BCBSM of operating an illegal monopoly and conspiring with other insurance companies in its network to fix prices, inflating premiums and out-of-pocket costs for Michigan consumers. "Blue Cross Blue Shield of Michigan has not yet been served and therefore we cannot comment on the specific merits of the case," the spokesperson wrote Thursday, adding that they "fundamentally disagree with the Attorney General's characterization of an uncompetitive insurance market in Michigan." Blue Cross Blue Shield of Michigan controls approximately 65% of all health insurance products and 79% of the PPO market in the state, according to the complaint. Nessel says the company's dominance has driven competing insurers out of the market, increasing costs and limiting provider options for consumers. "We brought this lawsuit for the millions of Michigan households, patients, parents, providers, doctors, small business owners, large employers and taxpayers, and consumers everywhere that are paying the price for Blue Cross's unchecked market power," Nessel said in a news release Thursday, calling the complaint "a significant step" toward ending the company's "illegal monopoly." Blue Cross disagrees with Nessel's characterization of its business practices. "Competition exists everywhere in our state's insurance markets, with strong local and national insurers competing with us every day," the Blue Cross statement said. " For nearly 90 years, Blue Cross has provided coverage for citizens across Michigan, in every county, without exception. This heritage, and the quality of products and services we provide, is foundational to our success in Michigan." The complaint is seeking hundreds of millions of dollars and a court order to stop the alleged practices.

Daily health news issue # 620 for 10/9/2026. Editor Notes (see table further below for links and summaries): * Biohacker Bryan Johnson is spending more than $2 million annually on AI-driven health monitoring and longevity interventions, hoping to extend human lifespan and make health rather than wealth the ultimate status symbol. * Michigan has filed an antitrust lawsuit against Blue Cross Blue Shield of Michigan, alleging the insurer used its market dominance and agreements with other Blue plans to limit competition, suppress provider payments, and drive up healthcare costs without lowering premiums. * The Blue denies this. * RFK is investigating vaccine-related injuries raising concerns among experts about scientific rigor and the potential impact on vaccine confidence amid rising measles cases. * Meanwhile, new CDC Director Dr. Erica Schwartz aims to replace the agency's "paternalistic" culture with greater transparency and public engagement while navigating contentious vaccine policies, staffing cuts, measles outbreaks, and emerging infectious disease threats. * The PBS Newshour piece talks about emerging research that suggests GLP-1 medications may help reduce drug and alcohol cravings, offering a potential new treatment option for substance use disorders. See its "top articles" list below. For a synoposis of all 50 articles curated today, see further below, and to see each of these articles listed with short summary just click here. Audio/Video. "A sickness known as hate; not a virus, not a microbe, not a germ, but a sickness nonetheless, highly contagious, deadly in its effects."... - Rod Serling, The Twilight Zone episode "I Am the Night - Color Me Black," 1964 | Article_Title | Article_Takeaway | | Kennedy Plans Federal Vaccine Injury Initiative, Drawing Wary Eye From Experts | Health Secretary Robert F. Kennedy Jr. is launching a new federal initiative to research vaccine injuries, sparking concern among experts regarding the scientific rigor of the effort. | | New CDC Director Is Eager to Change Its Culture | New CDC Director Dr. Erica Schwartz aims to eliminate paternalism at the agency, emphasizing better communication and transparency with the American public regarding health recommendations. | | What Experts Want to Know About the Russia Plague Scare | Scientists are calling for transparency from Russian health officials after the death of a laboratory worker in Siberia sparked fears of a potential plague outbreak. | | The Axios Show: Inside Bryan Johnson's quest to make 300 the new 70 | Biohacker Bryan Johnson, founder of the "Don't Die" movement, aims to shift societal focus from wealth to longevity through extreme data-driven health interventions. | | The evidence suggesting GLP-1s can curb drug and alcohol cravings | Researchers are studying whether GLP-1 medications, used for diabetes and weight loss, can effectively curb substance use disorder cravings, potentially offering a new tool to fight the national addiction crisis. | | UnitedHealthcare mistakenly tells members that 8 clinicians died | UnitedHealthcare sent erroneous letters to members incorrectly stating that eight physicians had died, leading to a prompt correction and an update in internal processes. | | Michigan Files Antitrust Suit Against Blue Cross Blue Shield Over Rising Costs | Michigan's attorney general has filed an antitrust lawsuit against Blue Cross Blue Shield of Michigan, alleging the insurer used its dominant market position to illegally drive up health insurance costs. | Today's graphic. Healthcare-Billionaire-Class (Source: -Forbes-September-2026). See below or click here Today's digest. Here is a summary of all 50 articles curated today into the Competitive Research Analytics Platform for 10/9/2026: Here is a summary of all the articles curated into the Competitive Research Analytics Platform for October 9, 2026: Millennial physicians are navigating a paradoxical financial landscape where record earnings are overshadowed by substantial student debt and limited private practice ownership opportunities compared to prior generations, creating long-term financial strain despite higher nominal compensation. Meanwhile, behavioral health is undergoing transformation, with Beacon Behavioral Partners leveraging platform scale to expand access to interventional psychiatry treatments including emerging therapies like psilocybin and TMS through operational and clinical support infrastructure. The medical device and healthcare sectors face significant regulatory and operational challenges. Becton Dickinson's $19 billion U.S. manufacturing commitment signals industry adaptation to tariff pressures, while CMS is intensifying price transparency enforcement across hospitals and insurers. Data security remains critical, as demonstrated by OU Health's patient breach involving unauthorized employee access and Advantest's ransomware attack compromising personally identifiable information. Utah's health AI sandbox is testing autonomous prescription pilots that may eventually conflict with FDA regulations, highlighting tension between innovation and oversight. Regulatory approvals and clinical advances are expanding treatment options. Novartis's Rhapsido received FDA approval as the first symptomatic dermographism treatment for inadequately controlled cases. Clinical trial extensions are proving essential for assessing long-term safety and durability, while chatbot interventions demonstrate efficacy in improving cancer risk knowledge among adolescents with hereditary predisposition. Emerging research suggests GLP-1 medications may address substance use disorder cravings, offering potential therapeutic applications beyond diabetes and weight management. Public health governance is experiencing significant transitions. New CDC Director Dr. Erica Schwartz is emphasizing transparency and communication, while Senator Patty Murray organizes efforts to protect the CDC from political interference. The Russia plague incident underscores the importance of laboratory biosafety and international transparency. Concurrently, health Secretary Robert F. Kennedy Jr. is launching a federal vaccine injury initiative, raising expert concerns about scientific rigor. Healthcare innovation is accelerating across multiple domains. WhiteLab Genomics raised $26 million for AI-designed genomic medicines, while healthcare AI investments are delivering 3.5x ROI within 12 months. Teladoc Health enhanced its virtual platform with ambient AI documentation and contactless vitals, and Relay Network partnered with Claritas Rx for specialty patient engagement. Clairity is disrupting traditional pathways by offering direct-to-consumer breast cancer risk assessments via AI for $249, though this raises questions about clinical validation and equity. Financial and operational challenges persist across the sector. Colorado is terminating its agreement with Freedom Care following fraud allegations and a $21 million annual spending spike. Kaiser Permanente agreed to repay potentially tens of millions in mistakenly withheld nurse wages. CMS is proposing a new contractor model emphasizing proactive fraud detection over reactive recovery, while penalizing 2,334 hospitals for high readmissions using combined Medicare Advantage and fee-for-service data. Market consolidation and competitive concerns continue emerging. Michigan filed an antitrust lawsuit against Blue Cross Blue Shield alleging anticompetitive market division and cost inflation. UnitedHealthcare's erroneous death notifications and the prevalence of non-Epic EHR systems among large health systems reflect ongoing operational complexities. Meanwhile, ACA Marketplace enrollment declined 12% following expiration of enhanced tax credits, with steepest declines in Republican-held districts. Patient-centered initiatives and emerging technologies offer promising solutions. Cigna launched Health Sense to personalize engagement for chronic condition management, while rural communities leverage peer support and community paramedicine for behavioral health access. Los Angeles County is implementing presumptive eligibility screening to reduce medical debt. Deloitte identified a $527 billion opportunity in women's health through earlier detection and prevention. Voice-first technology and biological aging assessments represent innovative approaches to accessibility and personalized health understanding, though questions about psychological impact and equity persist across these emerging tools. As of today, C.R.A.P. now has 238 subscribers. Want to drop FHIR-Engine a line? E-Mail Us